Ireland· IE-PA-PA0735/006/023
Omnipaque 240 mg I/ml Solution for Injection (Polypropylene)
A iohexol product containing iohexol, registered in Ireland by GE Healthcare AS. The same ATC class is registered in 17 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Iohexol is registered in 17 of 19 countries.
Countries holding a registration under ATC V08AB02 (iohexol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Iohexol · ATC V08AB02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Iohexol
- Manufacturer
- GE Healthcare AS
- Country
- Ireland (IE)
- ATC code
- V08AB02
- ATC class
- Iohexol
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0735/006/023
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
353 interactions on record for iohexol.
Graded by severity as the source publishes them — 286 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Iohexol · interactions on record
353 records
- 286 severe
- 54 moderate
- 13 info
Most severe, free to view
- MetoclopramideA03FA01severe
- ThiethylperazinA04AB03severe
- TriflupromazinA04AD06severe
- DronabinolA04AD10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Iohexol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumOmnipaque 240 mg I/mlGE Healthcare
- United KingdomOmnipaque 240 solution for injection 100ml plastic bottlesGE Healthcare Ltd
- NetherlandsOmnipaque 240 mg I/ml, injectievloeistofGE Healthcare B.V.
- NorwayOmnipaqueGE Healthcare AS
- SwedenOmnipaque 240 mg I/ml Injektionsvätska, lösningGE Healthcare AS
- SpainOMNIPAQUE 240 mg Iodo /ml SOLUCION INYECTABLEGe Healthcare Bio-Sciences, S.A.U.
- Japanイオヘキソール富士製薬工業
- CzechiaOMNIPAQUEGE Healthcare AS, Oslo
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Accupaque, Iovision
- Belgium · Omnipaque
- Bulgaria · Kopaq, Контамедиа Йох
- Cyprus · Omnipaque
- Czechia · Omnipaque
- Germany · Accupaque, Iovision
- Estonia · Iohexol Imax, Omnipaque
- Spain · Omnipaque
- Finland · Omnipaque
- France · Omnipaque
- United Kingdom (Northern Ireland) · Iohexol Farmak Pharmaceuticals Uk, Iohexol Ge Healthcare
- Greece · Omnipaque
- Croatia · Omnipaque
- Hungary · Iohexol Wogen, Omnipaque
- Iceland · Omnipaque
- Italy · Omnipaque
- Lithuania · Iohexol Icg Farma, Iohexol Imax
- Luxembourg · Omnipaque
- Latvia · Iohexol Imax, Omnipaque
- Malta · Omnipaque
- Netherlands · Iohexol Adoh, Omnipaque
- Norway · Omnipaque
- Poland · Omnipaque
- Portugal · Iohexol Imax, Omnipaque
- Romania · Omnipaque
- Sweden · Iovision, Omnipaque
- Slovenia · Omnipaque
- Slovakia · Omnipaque
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b11f1203-408f-4c5d-a4d8-e1d4400b0697 GET /v1/drugs/b11f1203-408f-4c5d-a4d8-e1d4400b0697?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Intraarterial use",
"Intrathecal use",
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"V08AB",
"V08AB02"
],
"strength": null,
"pa_number": "PA0735/006/023",
"substances": [
"Iohexol"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "23/03/2000",
"dispensing_status": "Product subject to Restricted Prescription (C)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about iohexol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.